Lizbeth Anne Littlewood
Fondatore presso Ixchelsis Ltd.
Posizioni attive di Lizbeth Anne Littlewood
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Ixchelsis Ltd.
 Ixchelsis Ltd. BiotechnologyHealth Technology Ixchelsis Ltd. develops oxytocin receptor antagonist for the treatment of premature ejaculation. It operates as a biotechnology company. The firm's product in pipeline IX-01 treats the male sexual health indication and premature ejaculation. The company was founded on July 27, 2011 by Gary John Muirhead, Lizbeth Anne Littlewood, Ian Howard Osterloh and Karl Richard Gibson and is headquartered in Sandwich, the United Kingdom. | Direttore operativo | 27/07/2011 | - |
| Fondatore | 27/07/2011 | - |
Storia della carriera di Lizbeth Anne Littlewood
Formazione di Lizbeth Anne Littlewood
| Sheffield Hallam University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
Posizioni
| Chief Operating Officer | 1 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Ixchelsis Ltd.
Ixchelsis Ltd. BiotechnologyHealth Technology Ixchelsis Ltd. develops oxytocin receptor antagonist for the treatment of premature ejaculation. It operates as a biotechnology company. The firm's product in pipeline IX-01 treats the male sexual health indication and premature ejaculation. The company was founded on July 27, 2011 by Gary John Muirhead, Lizbeth Anne Littlewood, Ian Howard Osterloh and Karl Richard Gibson and is headquartered in Sandwich, the United Kingdom. | Health Technology |